Literature DB >> 14663582

Toxoplasma gondii: changes of transepithelial ion transport in infected HT29/B6 cell monolayers.

Sabine Kowalik1, W Clauss, H Zahner.   

Abstract

An in vitro system was established to study the effect of coccidian parasites on ion transport systems in epithelial tissues using HT29/B6, a human colon carcinoma cell line, and Toxoplasma gondii as a model parasite. Ion transport was measured in perfusion chambers 5, 10 and 15 h post-infection using monolayers in which approximately 30% of the cells were parasitized. The infection had rapid effects on the conductance and unidirectional chloride fluxes of infected cell monolayers, which were two to three times higher than those of uninfected HT29/B6 cell monolayers throughout the observation period. However, the chloride net fluxes and short-circuit current were unaffected by the parasites, while the decrease of chloride seromucosal fluxes and conductance after addition of bumetanide were affected by the infection. The unidirectional mannitol fluxes, which correspond with water motion through paracellular pathways, were increased in infected HT29/B6 cell monolayers.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14663582     DOI: 10.1007/s00436-003-1033-0

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  25 in total

1.  Enteropathogenic Escherichia coli dephosphorylates and dissociates occludin from intestinal epithelial tight junctions.

Authors:  I Simonovic; J Rosenberg; A Koutsouris; G Hecht
Journal:  Cell Microbiol       Date:  2000-08       Impact factor: 3.715

Review 2.  Nutrient acquisition by intracellular apicomplexan parasites: staying in for dinner.

Authors:  K J Saliba; K Kirk
Journal:  Int J Parasitol       Date:  2001-10       Impact factor: 3.981

3.  Relationship between intracellular free calcium concentrations and the intracellular development of Toxoplasma gondii.

Authors:  L Pingret; J M Millot; S Sharonov; A Bonhomme; M Manfait; J M Pinon
Journal:  J Histochem Cytochem       Date:  1996-10       Impact factor: 2.479

4.  C. difficile toxin A increases intestinal permeability and induces Cl- secretion.

Authors:  R Moore; C Pothoulakis; J T LaMont; S Carlson; J L Madara
Journal:  Am J Physiol       Date:  1990-08

5.  Intracellular calcium and pH conditions of cultured cells infected with Eimeria bovis or E. separata.

Authors:  J H Behrendt; H Milde; W M Weber; S Kowalik; H Zahner; H J Bürger; W Clauss
Journal:  Parasitol Res       Date:  2000-04       Impact factor: 2.289

6.  Human intestinal cryptosporidiosis: secretory diarrhea and enterotoxic activity in Caco-2 cells.

Authors:  A Guarino; R B Canani; A Casola; E Pozio; R Russo; E Bruzzese; M Fontana; A Rubino
Journal:  J Infect Dis       Date:  1995-04       Impact factor: 5.226

7.  Cl- secretion in epithelial monolayers of mucus-forming human colon cells (HT-29/B6).

Authors:  K M Kreusel; M Fromm; J D Schulzke; U Hegel
Journal:  Am J Physiol       Date:  1991-10

8.  Rat intestinal epithelial cell line IEC-6 is activated by recombinant interferon-gamma to inhibit replication of the coccidian Toxoplasma gondii.

Authors:  I H Dimier; D T Bout
Journal:  Eur J Immunol       Date:  1993-04       Impact factor: 5.532

9.  Clostridium difficile toxin B disrupts the barrier function of T84 monolayers.

Authors:  G Hecht; A Koutsouris; C Pothoulakis; J T LaMont; J L Madara
Journal:  Gastroenterology       Date:  1992-02       Impact factor: 22.682

10.  Enterotoxic effect of stool supernatant of Cryptosporidium-infected calves on human jejunum.

Authors:  A Guarino; R B Canani; E Pozio; L Terracciano; F Albano; M Mazzeo
Journal:  Gastroenterology       Date:  1994-01       Impact factor: 22.682

View more
  1 in total

1.  Novel Colitis Immunotherapy Targets Bin1 and Improves Colon Cell Barrier Function.

Authors:  Sunil Thomas; Joanna M Mercado; James DuHadaway; Kate DiGuilio; James M Mullin; George C Prendergast
Journal:  Dig Dis Sci       Date:  2015-07-21       Impact factor: 3.199

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.